retatrutide peptide 60mg PT-141 10mg (Bremelanotide / Melanocortin
Description
Bulus, M
Employers who added GLP-1 coverage in 2022 and 2023 have watched pharmacy spending double or triple, and many are now pulling back
It also appears to dampen the reward signal that drives eating for pleasure rather than hunger, which may be especially relevant for people whose eating is tied to cravings or emotional triggers
In May 2022, tirzepatide also gained FDA approval for the treatment of adults with type 2 diabetes and obesity
Glucagonlike peptide agonists: a prospective review
Results The study included 289,809 adults (median age 54.6 years, 65.2% female, 69.2% with type 2 diabetes)
